Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2021 | Molecular mechanisms of cfDNA release in colorectal cancer

Federica Di Nicolantonio • 18 Oct 2021
ISLB 2021
Colorectal Cancer Gastrointestinal Cancer General

Federica Di Nicolantonio, MD, PhD, Candiolo Cancer Institute IRCCS, Turin, Italy, discusses why identifying molecular features, such as DNA methylation, that are associated with cfDNA release is important in the field of liquid biopsy. This interview took place at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting.

More from Federica Di Nicolantonio

1:17
The emerging role of ctDNA analysis and liquid biopsies in oncology
Federica Di Nicolantonio • 22 Oct 2023
1:03
Clinical subtyping of cancer from blood based on comprehensive epigenomic profiling
Federica Di Nicolantonio • 22 Oct 2023
0:55
Advanced ctDNA assay for pre-op lung cancer stratification
Federica Di Nicolantonio • 22 Oct 2023
1:07
CUPISCO: therapy guided by genomic profiling vs platinum-based chemotherapy in patients with CUP
Federica Di Nicolantonio • 22 Oct 2023

Related Videos

0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
1:33
Peptide vaccines with ICIs for fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals